![Janux Therapeutics Inc](/common/images/company/N_JANX.png)
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.42 | -9.75071696448 | 45.33 | 47.46 | 40.36 | 783743 | 42.60319761 | CS |
4 | -15.83 | -27.8991892845 | 56.74 | 61.59 | 40.36 | 1038604 | 50.2747949 | CS |
12 | -13.41 | -24.6870397644 | 54.32 | 71.71 | 40.0183 | 1122722 | 55.28712804 | CS |
26 | -4.16 | -9.23008653206 | 45.07 | 71.71 | 34.5125 | 825991 | 51.4881201 | CS |
52 | 31.51 | 335.212765957 | 9.4 | 71.71 | 7.79 | 831679 | 48.60764087 | CS |
156 | 26.46 | 183.114186851 | 14.45 | 71.71 | 5.65 | 339966 | 41.92219654 | CS |
260 | 6.91 | 20.3235294118 | 34 | 71.71 | 5.65 | 313137 | 40.22941067 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約